The Prognostic Value Of Ykl-40 In Allogeneic Hematopoietic Cell Transplantation

Although allogeneic hematopoietic cell transplantation (HCT) is a treatment option for a variety of malignant hematologic diseases, complications such as graft versus host disease (GVHD), infections and relapse are still major causes of morbidity and mortality. Prognostic scores such as the disease risk index and the HCT comorbidity index have proven useful in predicting relapse and treatment related mortality (TRM). However, to appropriately balance the likelihood of disease control against the risk of debilitating complications, still more accurate pretransplant markers are necessary to predict outcome.